The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture Of Pharmaceutical Preparations
No information on job gains number available
Announcement Date
10 April 2017
Employment effect (start)
1 January 2017
Foreseen end date
Description
Arkopharma is a French pharmaceutical company founded in 1980 manufacturing phytotherapeutic and natural drugs and food integrators. In 2017, the company decided to to close its manufacturing sites in Italy and Ireland and centralize the production activities in Carros (France). The company aimed to reduce its production over-capacity increasing its efficiency level. It also aimed to leverage on the made in effect. Huge investments were implemented also to improve the collaboration between the R&D and the production departments.
Sources
7 December 2017: Marie Claire Méditerranées (leblogmcmd.fr)
Eurofound (2017), Arkopharma, Reshoring in France, factsheet number 6, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/6.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
